Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Current Deferred Revenue (2023 - 2025)

Hinge Health's Current Deferred Revenue history spans 3 years, with the latest figure at $300.9 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 38.24% year-over-year to $300.9 million; the TTM value through Dec 2025 reached $300.9 million, up 38.24%, while the annual FY2025 figure was $300.9 million, 38.24% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $300.9 million at Hinge Health, roughly flat from $299.7 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $300.9 million in Q4 2025 and bottomed at $140.5 million in Q4 2023.
  • The 3-year median for Current Deferred Revenue is $217.6 million (2024), against an average of $233.0 million.
  • The largest annual shift saw Current Deferred Revenue skyrocketed 54.93% in 2024 before it surged 38.24% in 2025.
  • A 3-year view of Current Deferred Revenue shows it stood at $140.5 million in 2023, then skyrocketed by 54.93% to $217.6 million in 2024, then soared by 38.24% to $300.9 million in 2025.
  • Per Business Quant, the three most recent readings for HNGE's Current Deferred Revenue are $300.9 million (Q4 2025), $299.7 million (Q3 2025), and $275.1 million (Q2 2025).